Thalidomide-NH-C4-NH-Boc is a novel, potent, and selective class of Bromodomain-containing protein 4 (BRD4) and Bromodomain-containing protein 2 (BRD2) degrader for the development of therapeutics to treat cancers.
[1] Jiang F, et al. Bioorg Med Chem. 2020 Jan 1;28(1):115181.
















